Investing
Investment Purchases
Neurocrine Biosciences Investment Purchases increased by 153.7% to $819.50M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 200.0%, from $273.20M to $819.50M. Over 4 years (FY 2021 to FY 2025), Investment Purchases shows an upward trend with a 13.3% CAGR.
Analysis
StatementCash Flow Statement
SectionInvesting
CategoryLiquidity
SignalContext dependent
VolatilityModerate
First reportedQ1 2013
Last reportedQ1 2026May 5, 2026
How to read this metric
An increase may indicate a strategy to earn interest on excess cash, while a decrease may suggest a need for cash for operations or debt repayment.
Detailed definition
This metric captures the cash outflow for the purchase of marketable securities, such as stocks, bonds, or other financi...
Peer comparison
Standard for large-cap companies with significant cash reserves; peers manage these portfolios to balance liquidity needs with yield generation.
Metric ID:
purchases_of_investmentsHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $289.40M | $275.60M | $141.40M | $192.80M | $60.90M | $134.20M | $233.30M | $206.20M | $323.80M | $362.70M | $487.20M | $320.10M | $191.70M | $232.50M | $311.80M | $273.20M | $315.10M | $408.50M | $323.00M | $819.50M |
| QoQ Change | — | -4.8% | -48.7% | +36.4% | -68.4% | +120.4% | +73.8% | -11.6% | +57.0% | +12.0% | +34.3% | -34.3% | -40.1% | +21.3% | +34.1% | -12.4% | +15.3% | +29.6% | -20.9% | +153.7% |
| YoY Change | — | — | — | — | -79.0% | -51.3% | +65.0% | +7.0% | +431.7% | +170.3% | +108.8% | +55.2% | -40.8% | -35.9% | -36.0% | -14.7% | +64.4% | +75.7% | +3.6% | +200.0% |
Range$60.90M – $819.50M
CAGR+24.5%
Avg YoY Growth+57.7%
Median YoY Growth+31.1%
Investment Purchases at Other Companies
Frequently Asked Questions
- What is Neurocrine Biosciences's investment purchases?
- Neurocrine Biosciences (NBIX) reported investment purchases of $819.50M in Q1 2026.
- How has Neurocrine Biosciences's investment purchases changed year-over-year?
- Neurocrine Biosciences's investment purchases increased by 200.0% year-over-year, from $273.20M to $819.50M.
- What is the long-term trend for Neurocrine Biosciences's investment purchases?
- Over 4 years (2021 to 2025), Neurocrine Biosciences's investment purchases has grown at a 13.3% compound annual growth rate (CAGR), from $800.10M to $1.32B.
- What does investment purchases mean?
- Cash used to buy financial assets or securities.